Access the full text.
Sign up today, get DeepDyve free for 14 days.
LA Meillon‐Garcia, R Demichelis‐Gómez (2020)
Access to therapy for acute myeloid leukemia in the developing world: barriers and solutions, 22
K. Nakata, S. Okawa, S. Fuji, Akira Sato, T. Morishima, Y. Tada, M. Inoue, J. Hara, K. Kawa, I. Miyashiro (2021)
Trends in survival of leukemia among children, adolescents, and young adults: A population‐based study in Osaka, JapanCancer Science, 112
SL Chen, H Zhang, RP Gale (2021)
Toward the cure of acute lymphoblastic leukemia in children in China, 7
Xiangjie Lin, Jinghan Wang, Xin Huang, Huafeng Wang, Fengling Li, Wenle Ye, Shujuan Huang, Jiajia Pan, Qing Ling, Wenwen Wei, Shihui Mao, Yu Qian, Jie Jin, Jian Huang (2021)
Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 studyAging (Albany NY), 13
SE Fischer, OI Alatise, AO Komolafe (2017)
Establishing a cancer research consortium in low? and middle?income countries: challenges faced and lessons learned, 24
Y Dong, O Shi, Q Zeng (2020)
Leukemia incidence trends at the global, regional, and national level between 1990 and 2017, 9
U Platzbecker, AS Kubasch, C Homer‐Bouthiette, T Prebet (2021)
Current challenges, and unmet medical needs in myelodysplastic syndromes, 35
D Sun, M Cao, H Li, S He, W Chen (2020)
Cancer burden and trends in China: a review and comparison with Japan and South Korea, 32
R Sankaranarayanan, K Ramadas, YL Qiao (2014)
Managing the changing burden of cancer in Asia, 12
Mariane Faria-Moss, M. Yamamoto, C. Arrais-Rodrigues, I. Criado, C. Gomes, Maria Chauffaille, M. Gonçalves, E. Kimura, E. Koulieris, Fabio Borges, G. Dighiero, J. Pesquero, J. Almeida, A. Órfão (2019)
High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in BrazilHaematologica, 105
Shama Virani, Surichai Bilheem, Wasan Chansaard, I. Chitapanarux, K. Daoprasert, Somsak Khuanchana, A. Leklob, D. Pongnikorn, L. Rozek, Surattaya Siriarechakul, K. Suwanrungruang, S. Tassanasunthornwong, P. Vatanasapt, H. Sriplung (2017)
National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest BurdensCancers, 9
A Eniu, NI Cherny, M Bertram (2019)
Cancer medicines in Asia and Asia?Pacific: what is available, and is it effective enough?, 4
Jung-ah Kim, Byungjin Hwang, S. Park, Sunghoon Huh, Kyongok Im, Sungbin Choi, Hye Chung, J. Huh, E. Seo, Je-Hwan Lee, D. Bang, D. Lee (2016)
Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted SequencingPLoS ONE, 11
Dong-Wook Kim, S. Banavali, U. Bunworasate, Y. Goh, P. Ganly, He Huang, I. Irving, S. Jootar, Hyun-gyung Goh, L. Koh, Wei Li, T. Naoe, S. Ng, V. Purushotaman, H. Reksodiputro, L. Shih, Jih-Luh Tang, A. Tojo, Jianmin Wang, Raymond Wong (2010)
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era.Leukemia research, 34 11
Seri Hong, Y. Won, Jae Lee, K. Jung, H. Kong, J. Im, H. Seo (2021)
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018Cancer Research and Treatment : Official Journal of Korean Cancer Association, 53
AE Yeoh, D Tan, CK Li, H Hori, E Tse, CH Pui (2013)
Asian Oncology Summit 2013. Management of adult and pediatric acute lymphoblastic leukemia in Asia: resource?stratified guidelines from the Asian Oncology Summit 2013, 14
D Duarte, ED Hawkins, C Lo Celso (2018)
The interplay of leukemia cells and the bone marrow microenvironment, 131
W. Au, P. Caguioa, C. Chuah, S. Hsu, S. Jootar, Dong-Wook Kim, Il-Young Kweon, W. O’Neil, T. Saikia, Jianxiang Wang (2009)
Chronic myeloid leukemia in AsiaInternational Journal of Hematology, 89
The burden of leukemia and related diseases is rapidly growing in Asia. Currently, there is a paucity of regional collaborative groups/initiatives that focus exclusively on the management of leukemia in the Asia‐Pacific (APAC) region. The Asia‐Pacific Leukemia Consortium (APLC) was established on the 8 September 2021 to understand the status quo, unmet needs, and ways to improve the management of leukemia and related diseases in the APAC region. The APLC working group set up a group of experts from various countries (Singapore, Malaysia, Thailand, Hong Kong, Japan, South Korea, Taiwan, China, and Australia) to discuss on the status of: (i) clinical trials; (ii) disease registry database; (iii) genetic and tissue repository; (iv) patient advocacy and care; and (v) disease prevention and education in the APAC region. Low levels of awareness about leukemia amongst the public, lack of financial support, and limited access to newly approved therapies were identified as barriers to the implementation of effective leukemia management in low‐ or mid‐income Asian countries. Patients often enroll in clinical trials to gain access to novel/approved therapies. The APLC group aims to address the growing threat of leukemia through a collaborative approach to advance disease prevention, research, clinical trials, and education.
Asia-Pacific Journal of Clinical Oncology – Wiley
Published: Dec 1, 2023
Keywords: Asia‐Pacific; burden; collaboration; leukemia; status quo
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.